(Q28255152)

25 March 2017

2

Paul G Ambrose

0 references

author name string

Robert C Owens

series ordinal

1

0 references

R. C. Owens

series ordinal

1

1 reference

25 March 2017

P. G. Ambrose

series ordinal

2

1 reference

25 March 2017

language of work or name

English

0 references

publication date

15 July 2005

1 reference

Clinical Infectious Diseases

25 March 2017

published in

1 reference

25 March 2017

volume

41 Suppl 2

0 references

41

1 reference

25 March 2017

issue

Supplement 2

1 reference

25 March 2017

page(s)

S144-57

0 references

S144-S157

1 reference

Fluoroquinolone toxicity profiles: a review focusing on newer agents

25 March 2017

cites work

1 reference

Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy

21 January 2018

1 reference

Torsades de pointes associated with fluoroquinolones

21 January 2018

1 reference

Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the United States Food and Drug Administration Adverse Event Reporting System

21 January 2018

1 reference

Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies

21 January 2018

1 reference

Gatifloxacin, Gemifloxacin, and Moxifloxacin: The Role of 3 Newer Fluoroquinolones

21 January 2018

1 reference

Gatifloxacin in community-based treatment of acute respiratory tract infections in the elderly

21 January 2018

1 reference

Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.

21 January 2018

1 reference

Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis

21 January 2018

1 reference

Clinical use of the fluoroquinolones

21 January 2018

1 reference

Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin

21 January 2018

1 reference

Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections

21 January 2018

1 reference

Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites

21 January 2018

1 reference

Structure-activity and structure-side-effect relationships for the quinolone antibacterials

21 January 2018

1 reference

Possible gatifloxacin-induced seizure

21 January 2018

1 reference

QT prolongation with antimicrobial agents: understanding the significance

21 January 2018

1 reference

Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes

21 January 2018

1 reference

Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors

21 January 2018

1 reference

MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia

21 January 2018

1 reference

Antimicrobial pharmacodynamics.

21 January 2018

1 reference

Clinical pharmacodynamics of quinolones

21 January 2018

1 reference

Clinical experience with moxifloxacin in patients with respiratory tract infections

21 January 2018

1 reference

Increase in insulin release from rat pancreatic islets by quinolone antibiotics

21 January 2018

1 reference

Quinolone antibacterials. An update of their pharmacology and therapeutic use.

21 January 2018

1 reference

Glyburide-ciprofloxacin interaction with resistant hypoglycemia

21 January 2018

1 reference

Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise.

21 January 2018

1 reference

Profile of moxifloxacin drug interactions

21 January 2018

1 reference

Possible gatifloxacin-induced hyperglycemia

21 January 2018

1 reference

Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction

21 January 2018

1 reference

Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies

21 January 2018

1 reference

Hypoglycemia in hospitalized nondiabetic older patients.

21 January 2018

1 reference

Hypoglycemia as a predictor of mortality in hospitalized elderly patients

21 January 2018

1 reference

Quinolone arthropathy in animals versus children

21 January 2018

1 reference

Fluoroquinolones and risk of Achilles tendon disorders: case-control study

21 January 2018

1 reference

Increased risk of achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids

21 January 2018

1 reference

Quinolone hypersensitivity

21 January 2018

1 reference

Fatal anaphylaxis associated with ciprofloxacin in a patient with AIDS related complex

21 January 2018

1 reference

Temafloxacin syndrome: review of 95 cases

21 January 2018

1 reference

Clinical toxicological aspects of fluoroquinolones

21 January 2018

1 reference

Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.

21 January 2018

1 reference

Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection

21 January 2018

1 reference

Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection?

21 January 2018

1 reference

Nosocomial acquisition of Clostridium difficile infection

21 January 2018

1 reference

Risk factors for Clostridium difficile infection

21 January 2018

1 reference

Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem

21 January 2018

1 reference

Elevated levels of serum immunoglobulins in asymptomatic carriers of Clostridium difficile

21 January 2018

1 reference

Fluoroquinolone use and Clostridium difficile-associated diarrhea.

21 January 2018

1 reference

Quinolone use as a risk factor for nosocomial Clostridium difficile-associated diarrhea

21 January 2018

1 reference

Ciprofloxacin and Clostridium difficile--associated diarrhea

21 January 2018

1 reference

Antimicrobial associations of an outbreak of diarrhoea due to Clostridium difficile.

21 January 2018

1 reference

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

21 January 2018

1 reference

Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam

21 January 2018

1 reference

Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora

21 January 2018

1 reference

New antibiotics in pulmonary and critical care medicine: focus on advanced generation quinolones and cephalosporins

21 January 2018

1 reference

Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use--safety report

21 January 2018

1 reference

Safety profile of quinolone antibiotics in the pediatric population

21 January 2018

1 reference

Open label, multicenter study of gatifloxacin treatment of recurrent otitis media and acute otitis media treatment failure

21 January 2018

1 reference

Fluoroquinolones in the elderly: safety considerations

21 January 2018

1 reference

Optimizing antimicrobial dosing in the critically ill patient

21 January 2018

1 reference

Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly

21 January 2018

1 reference

21 January 2018

Toxicity of quinolones

1 reference

Effect of quinolones on intestinal ecology

21 January 2018

1 reference

21 January 2018

Quinolones in the aged

1 reference